简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-09-02 12:30 Kaneka Completes Construction of Medical Device Plant in Hokkaido
2024-08-30 08:01 Merck Announces First Patient Dosed in Phase III Study of Oral Cladribine in Generalized Myasthenia Gravis (gMG)
2024-08-29 14:38 Galderma Successfully Issued an Inaugural CHF 500 Million Bond
2024-08-29 13:12 HistoSonics™ Partners with Li Ka Shing Foundation to Launch First Histotripsy Programs in Hong Kong
2024-08-29 12:44 Novotech Earns Renewed Certification as an Employer of Choice for Gender Equality
2024-08-28 16:56 Lubrizol Opens Beauty Research Institute in Shanghai, China
2024-08-26 11:06 European Commission approves Celltrion’s SteQeyma® (CT-P43), a biosimilar to Stelara® (ustekinumab), for the treatment of multiple chronic inflammatory diseases
2024-08-26 11:02 HemoHim's Global Market Success Rooted in Rigorous Quality Control
2024-08-23 13:11 PCI Pharma Services’ Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
2024-08-22 08:24 Innovo Therapeutics Inc. Announces Phase 2 Clinical Results Demonstrating the Innovative Efficacy of INV-001 for the Treatment of Post-thyroidectomy Scars
2024-08-21 10:47 Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
2024-08-20 11:35 Guard Medical Announces FDA 510(k) Clearance for Additional Large Sizes of Its Novel NPseal® NPWT Surgical Dressing, Unlocking the Orthopedic Market
2024-08-13 13:08 Galderma Receives U.S. FDA Approval for Nemluvio® (nemolizumab) for Adult Patients Living With Prurigo Nodularis
2024-08-09 15:17 Morinaga Milk Obtains the Registration of "New Food Ingredient" in China for use of its Probiotic Bifidobacterium infantis M-63 in Infant Foods
2024-08-09 14:40 Nichi BRITE Beta glucan as an onco-nutrition supplement in pancreatic cancer; Encouraging clinical results reported by Chikamori Hospital, Japan.
2024-08-09 13:03 BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates
2024-08-08 16:24 Parse Biosciences Partners with Taiwan-based Prisma Biotech to Extend Reach in Asia
2024-08-08 10:11 Takeda Receives European Commission Approval for ADZYNMA®▼ (Recombinant ADAMTS13) as the First and Only Recombinant ADAMTS13 Replacement Therapy for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
2024-08-05 13:47 Galderma to pursue a new scientific partnership with L’Oréal to further advance its category leadership in dermatology
2024-08-01 14:15 Takeda Announces First Quarter FY2024 Results - Strong Performance by Growth & Launch Products; Advancements in Promising Late-Stage Pipeline

Business Wire Weibo

Press Releases

Latest Releases